Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Or whoever put it on the website copy and pasted random antibody information, assuming they're all the same.
Exceptions aren't the only necessary proof, policy language can be - which I did point to. You likewise can't hold to policies if you don't acknowledge all of them, and the room they provide.
I also can't prove a snake can find it's way into my chicken coop, since it hasn't happened yet. Doesn't mean I don't pretend the scenario may come and I will need to react. See my chicken coop has these small hole openings.. just the right size for a snake.
Thank you, good post/information.
Incorrect, but thanks for your opinion.
Incorrect, always was Jiangsu Dablood.
Assurance AB (Jiangsu DaBlood) still listed on FDA FAQ for tests offered but not yet authorized.
https://www.fda.gov/medical-devices/emergency-situations-medical-devices/faqs-diagnostic-testing-sars-cov-2
This is a question I also have. If I were short, I would buy a fair amount of shares in the few days following, then eventually sell at low numbers to incite fear and drive the price downward for covering initial.
No idea though, but could see a few ways to still manipulate to get the low prices desired. If anything, see more potential for manipulation given likely even less oversight.
Extremely uneducated opinion, would love thoughts of others as well (especially if anyone has experience).
"Never have" vs "never could" is a very important distinction to be made. Might not be worth acknowledging given 0/3000+ success rate, but it's still an open potential.
Thanks for the thoughts Mazeppa. I agree, the high-suspension volume is noteworthy on many accounts.
IMO a heavier and swifter hand also comes with a higher likelihood of mistake. Trying to treat this time period, and companies involved, as apart of the normal statistics is a stretch. BUT, it is still a very very low probability for any company to be an exception.
If there was an exception though, it would be at a time like this. I personally believe we will likely wait the 10 days and hit the greys, but think there is potential otherwise that needs to be acknowledged.
Agree. Lots of speculation and cherry picked statistics/info that is frankly irrelevant until we either see tests delivered, a statement by the company, or end of suspension.
For those looking for more information right now, you can either go look at the actual policy language (FINRA, SEC) or look at this helpful pdf from the SEC:
https://www.sec.gov/investor/alerts/tradingsuspensions.pdf
Monday should be telling due to stated window timing, one way or another IMO.
So sorry, you have no policy basis.
PRED has also been shown erroneously on both the Nasdaq and QX at times. I would not take system generated exchanges (suspect to error and/or imperfectly aligned code) as overwriting FINRA.
Per FINRA... no more than 4 consecutive business days can pass. Per my count we've had 4, but not MORE [business days].
We can trade on the PINKs on Monday open if there has been any suspension reversal (hopefully PRED continues to quickly prove legitimacy). If anyone has any policy language otherwise, please show.
I assumed AB stood for Antibody, didn't think of blood though.
Their other listed product Assurance VR (Thermo Taqpath) likely stands for Viral RNA, which is what their testing for so see potentially more in line with antibody.
Regardless, agree with donation!
SEC does not discuss with a company prior to suspension. They do an initial investigation, suspend, and then investigate more fully with non-public information that can (although rarely) clarify/legitimize. The process is meant to eliminate any connections and bias.
IMO We likely know why they were suspended as a few here noted (CN NMPA registration concern), but we also hashed through a few reasons that PRED may be very well in the clear. Products delivered or quick back to OTC will clear.. and good news is either should be quick to assess (good/bad).
Quiet can mean many things, but I would personally take it as the company spending all of their efforts with the SEC to clarify. Let them handle in private (especially since there's a likelihood of someone getting a black eye.. best way to handle politically at present), but an update will surely come soon.
Given the urgency of kit need, can not see anything but air-freight be used (especially considering how few pallets it should take to ship large quantities).
Incorrect. "Questions regarding accuracy and adequacy of information".
Incorrect. Please have the SEC put "suspended for fraud" in writing. Statement is not definitive and only demonstrated ongoing investigations due to questions (that require further confidential detail to evaluate).
Sorry, no PMs. I am not saying tests have been delivered (no idea, have not seen evidence). I am saying delivered tests are the true proof in this scenario (along with continued listing on the FDA FAQ if not EUA).
Good news is we will know very quickly, as 1M tests distributed don't need reliance on a PR/company statement... you should be able to call up a local clinic and get one.
Incorrect. "Questions regarding accuracy and adequacy of information".
Incorrect. "Questions regarding accuracy and adequacy of information".
Agree, and what our new friends don't comprehend is that our leadership has stuck with the company over VERY trying times. Extremely powerful and influential people, who I can only imagine are frankly pissed.
That anger will be directed, and will also be a very large tell of truth. BUT if the company has been acting well... when you have connections directly to the President (Orrin), in a time like this, exceptions and norms are much more likely to be shaken. JMO
Physical tests delivered. Pretty simple.
IMO, if PRED was anything close to a scam it would have been hashed out in July of last year from the first HB report. You can be damned sure there was internal review at depth by both the board of directors and the scientific board.
But.. they stayed. Orrin Hatch, 42 year senator. John Nelson, Ex-President of the American Medical Association. Hugh Taylor, Yale Chair of Gynecology and Reproductive Medicine. Ron Barhorst, Ex-President of ING Financial. Mike Dey, President Wyeth Women's Health. John Sorrentino, VP Vaccine Research Pfizer. They have also employed WSGR and Deloitte Touche. Off the top of my head, I'm sure there are more.
They were likely chosen because the SEC is casting a wide net and their claim seemed too good to be true, especially for a pink sheet. Hindenburg/Regenexx has also been very vocal in distorting truth, jumping to negative conclusions, and only focusing on the stem cell business (until now). Keep in mind that the SEC has been more aggressive due to COVID scams and impact, but that aggression comes with more potential for false flags.
Again.. we wait for the truth, which I fully welcome.
Yep. Time to take a full break from the board until it appears we will be trading again or the company makes a statement.
Seems like the SEC is halting many COVID stocks. IMO will put to bed the question of scam or not.. hopefully mgmt uses this opportunity to come out and crush the shorts.
Definitely a fake review.
IMO The traditional model of cornering a market doesn't really apply here. Demand is so significant that every manufacturer (assuming right specificity/sensitivity, and eventual EUAs) will sell every test produced.
Would also say that more tests helps not hurts PRED, as the testing option becomes a viable candidate for large-scale public and private reopening plans.
Just remember, PRED could have business operations on near complete hold right now if they were not ahead of the 8-ball... seems like very competent management to me. Very proud of the team to forsee this, while I and many others were skeptical initially.
Revisiting CN registration after looking at DaBlood's website again.
http://www.jsdablood.com/index.php/list/bonade/1/cn/6890/4044.html
Although outdated, pretty clear DaBlood doesn't normally do full kits or anything beyond test strips. In an interview with the Sun Yat-Sen University contact, they also mentioned that the DaBlood does not sell fill kits and therefore would not register with the government. I previously assumed they built either the full kit or at least the cassette, which appears incorrect.
Remember PRED referenced two things in their article.. the 38m manufactured, and the registration to the best of their knowledge.
I would think these strips are sold to overall manufacturers who subassemble the test kits together (plastic, diluent, etc), and why my previous post showed a ton of relation to Wondfo for instance (who is registered). Pred either does the sub assembly themself or contracts it.
This would make sense of both of PREDs statements. The 38m would make sense if they were the critical component subtier, and why people have a hard time trying the numbers. The registration note also makes sense, because likely PRED and DaBlood can not publicly state which overall manufacturers use the strips without dablood's consent.
Guess we'll see.
For those questioning the 1.5m kits/day from DaBlood, saw an interesting line that may help provide data to justify:
http://www.jsdablood.com/userlist/bonade/text-4043.html
Light volume may be an indicator that... something is going on.
Donald Trump Public Schedule:
https://factba.se/topic/calendar
3:30pm meeting with healthcare executives
5:00pm press briefing
...seems like a great time to announce authorization of the much discussed antibody tests. Could see the news being big enough that the President himself wants to break it.
"By one estimate, America may need 35 million Covid-19 tests per day for people to return to work."
https://www.vox.com/2020/4/13/21215133/coronavirus-testing-covid-19-tests-screening
I don't think there's any problem with competition. Good luck to all manufacturers who have the ability to ramp capacity. PRED will sell every unit they can regardless.
Remember, while a media splash will be nice (and near-destined upon EUA), we'll always be validated in the end with financial results.
Remember market cap difference. But yes, FDA EUAs updated nightly on website (Mon-Fri ~10pm EST historically). Announcement would follow tomorrow morning if correct.
Brad still listed on Yahoo/Bloomberg...
https://finance.yahoo.com/quote/PRED/profile?p=PRED
https://www.bloomberg.com/quote/PRED:US
WSJ does miss him on the executive lists, but still calls him out as director/CEO in the insider transaction section to the right.
https://www.wsj.com/market-data/quotes/PRED/company-people
I wouldn't take one aggregate data website error over an 8k. John has announced news in the past. No change-up expected, especially while pending nasdaq and during short attacks.